Ms. Lumaris Perez, B.A PSYCHOLOGY Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 9 Pierpont St, Pebody, MA 01960 Phone: 978-304-3752 |
News Archive
Leaving the house in the morning may seem simple, but with every move we make, our brains are working feverishly to create maps of the outside world that allow us to navigate and to remember where we are.
A recent study by Dr Christina Haston, a researcher of the McGill University Health Centre research Institute, sheds some new light on the bone problems that generally accompany cystic fibrosis.
The World Health Organization (WHO) said on Tuesday that there was no chance the agency would attempt to vaccinate Yemen against cholera due to the fact that the disease has spread so widely there that such an effort would be fruitless. This is a U-turn on a decision made by the organization a month ago. On June 15th this year, the WHO had decided to send one million doses of cholera vaccine to Yemen in collaboration with some other partners. This was following a request from Yemen's internationally recognized government. This new decision revokes the earlier plans.
Chembio Diagnostics, Inc., which develops, manufactures, markets and licenses point-of-care diagnostic tests, has been notified that Bio-Manguinhos, a division of the Oswaldo Cruz Foundation of Brazil ("FIOCRUZ"), has received regulatory approval from Brazil's National Health Surveillance Agency (Anvisa) to market Chembio's Dual Path Platform (DPP®) HIV 1/2 rapid test for use with oral fluid, blood, serum or plasma samples. The approval triggers $400,000 in license revenues payable to Chembio within 120 days of the date of approval.
› Verified 5 days ago